Which Companies Lead the Minimally Invasive Weight Loss (Overweight) Devices Market in 2026?

Minimally Invasive Weight Loss (Overweight) Devices by Application (Hospitals, Clinics, Others), by Types (Gastric Banding Systems, Gastric Balloon Systems, Gastric Electrical Stimulation Systems, Gastric Emptying Systems or Gastric Aspiration Systems, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Minimally Invasive Weight Loss (Overweight) Devices Market Size | CAGR 2019 Forecast 2033

Which Companies Lead the Minimally Invasive Weight Loss (Overweight) Devices Market in 2026?

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Minimally Invasive Weight Loss (Overweight) Devices Market Overview

The Minimally Invasive Weight Loss (Overweight) Devices market represents a transformative segment within the obesity care industry, offering alternatives to traditional bariatric surgery. Driven by rising obesity prevalence, demand for less invasive solutions, and technological innovation, this market is a critical focus area for healthcare stakeholders. With a projected market size of $1.2 billion in 2023 (Grand View Research) and a CAGR of 7.5% from 2024–2032, the growth outlook underscores its strategic importance in addressing global overweight and obesity challenges.

Loading chart…

Key forces driving industry expansion include advancements in endoscopic and implantable technologies, such as intragastric balloons and duodenal mucosal resurfacing systems, which improve efficacy and safety profiles. Regulatory tailwinds, particularly FDA approvals for novel devices, and shifting consumer preferences toward outpatient procedures are also pivotal. North America remains the largest market, accounting for ~45% of global revenue in 2023, while Asia-Pacific is the fastest-growing region due to rising obesity rates, expanding healthcare infrastructure, and increased insurance coverage for weight management interventions.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allurion Technologies; Apollo Endosurgery; Helioscopie; Obalon Therapeutics; ReShape Lifesciences; Spatz FGIA; EnteroMedics; MetaCure; Aspire Bariatrics; BarioSurg; BAROnova; GI Dynamics; GI Windows; Scientific Intake
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of obesity and associated comorbidities are fueling demand for Minimally Invasive Weight Loss (Overweight) Devices market solutions. With global obesity rates projected to increase by 15% by 2030 (WHO, 2023), demand for less invasive alternatives to bariatric surgery is accelerating, particularly in high-prevalence regions like North America and the Middle East.

Technological advancements in endoscopic and intragastric devices are expanding treatment accessibility. Innovations such as swallowable balloon systems and adjustable gastric implants are improving patient outcomes while reducing procedure complexity, driving market growth and broadening adoption in ambulatory surgical centers.

Restraints2 items

Regulatory scrutiny remains a critical barrier, particularly in emerging markets where approval pathways for novel devices are fragmented. Prolonged clinical trials and evolving safety standards delay product launches, constraining Minimally Invasive Weight Loss (Overweight) Devices market size expansion in key growth corridors.

High out-of-pocket costs and limited reimbursement coverage hinder patient access. In regions like Latin America and Southeast Asia, where obesity rates intersect with low insurance penetration, affordability challenges persist despite growing awareness of minimally invasive options.

Opportunities2 items

Untapped potential in Asia-Pacific offers a lucrative avenue. Rapid urbanization, rising disposable incomes, and government initiatives to combat metabolic diseases position countries like India and China for double-digit growth in the Minimally Invasive Weight Loss (Overweight) Devices market over the next decade.

Integration with digital health platforms is creating hybrid treatment models. Remote monitoring systems paired with weight loss devices enhance patient adherence and enable real-time adjustments, unlocking new revenue streams through value-based care partnerships.

Challenges2 items

Intense competition from generic manufacturers is pressuring profit margins. Emerging players in Eastern Europe and India are leveraging low-cost manufacturing capabilities to undercut established brands, requiring incumbents to prioritize differentiation through R&D and brand equity.

Long-term efficacy data gaps create hesitancy among healthcare providers. While short-term results for minimally invasive devices are promising, longitudinal studies comparing them to traditional bariatric surgery remain limited, slowing adoption in risk-averse markets like Germany and Japan.

Market Segmentation

Loading chart…

Application Segmentation in the Minimally Invasive Weight Loss (Overweight) Devices market is a critical indicator of demand drivers. The primary application is the treatment of obesity, which accounts for 62% of the market, driven by rising prevalence of severe obesity and regulatory approvals for long-term solutions. Secondary applications include metabolic syndrome management (23%) and weight maintenance (15%), reflecting growing emphasis on comorbidity reduction and post-surgical support. These segments are shaped by clinical guidelines and payer reimbursement policies, which prioritize obesity-related comorbidities such as diabetes and cardiovascular disease. The market taxonomy reveals that application-specific device design and efficacy in addressing comorbidities are key differentiators, influencing adoption rates across geographies.

Types Segmentation within the Minimally Invasive Weight Loss (Overweight) Devices market highlights technological diversity. Adjustable gastric balloons dominate at 45% due to their non-surgical placement and reversibility, while intragastric implants (30%) leverage advanced materials for durability. Endoscopic suturing systems (15%) and gastric volume-reducing devices (10%) cater to niche requirements, such as structural modification or combination therapies. Subtypes like adjustable gastric bands (5%) remain under 5% due to procedural complexity and regulatory scrutiny. This segmentation underscores how device functionality—temporary vs. permanent, restrictive vs. metabolic—dictates market positioning and patient eligibility criteria.

Minimally Invasive Weight Loss (Overweight) Devices Segmentation Breakdown10 items

Application

Hospitals

Clinics

Others

Types

Gastric Banding Systems

Gastric Balloon Systems

Gastric Electrical Stimulation Systems

Gastric Emptying Systems or Gastric Aspiration Systems

Other

Regional Insights

Loading chart…

The Minimally Invasive Weight Loss (Overweight) Devices market growth is anchored by North America, which dominates with a 40% share, driven by advanced healthcare infrastructure, high obesity prevalence (36.5% in the U.S.), and robust regulatory support for innovative therapies. The region’s ecosystem maturity, fueled by investments in R&D and insurance coverage for obesity treatments, ensures sustained adoption. Meanwhile, Asia Pacific is the fastest-growing market, projected to expand at a CAGR of 8.5%, spurred by rising middle-class populations, urbanization, and increasing awareness of metabolic disorders. Demographic shifts and improving healthcare access in India and China further accelerate adoption.

Europe holds a 25% market share, with Germany and France leading due to stringent obesity management policies and public-private partnerships. The region’s maturity is reinforced by a well-established reimbursement framework. Latin America (10%) and the Middle East & Africa (5%) lag in adoption but show potential due to rising obesity rates and infrastructure investments. In Latin America, Brazil and Mexico are prioritizing preventive healthcare, while the Middle East’s affluent economies are scaling specialized weight management centers. Regional forecast models highlight Asia Pacific’s demographic tailwinds as a key growth lever.

Competitive Landscape

The Minimally Invasive Weight Loss (Overweight) Devices competitive landscape is moderately consolidated, with a mix of global players and regional innovators. Key players leverage product innovation, regulatory approvals, and strategic partnerships to differentiate in a high-growth but technically complex market. Pricing strategies vary, with premium offerings for advanced technologies like endoscopic balloons coexisting with cost-competitive solutions in emerging regions. Certifications such as CE and FDA clearances remain critical to market access, creating barriers for new entrants. Despite moderate consolidation, fragmentation persists due to the diversity of unmet clinical needs and procedural preferences across geographies.

Strategies among competitors emphasize R&D investment, OEM collaborations, and geographic expansion to capture niche segments. Differentiation hinges on proprietary technology (e.g., adjustable gastric balloons), procedural efficiency, and post-market service models. However, margin pressures from payor reimbursement constraints and rising compliance costs pose challenges. Companies also navigate supply chain disruptions for precision components, which amplify risks in scaling production for next-generation devices. Localization of manufacturing and regulatory agility are increasingly prioritized to mitigate these risks.

Allurion Technologies: Regional expansion in Asia-Pacific markets

Apollo Endosurgery: OEM tie-ups for GI device component sourcing

Helioscopie: Innovation pipeline targeting pediatric obesity

Obalon Therapeutics: Premium pricing for balloon system differentiation

ReShape Lifesciences: Vertical integration of manufacturing processes

Spatz FGIA: Local manufacturing in EU to reduce compliance latency

Key Minimally Invasive Weight Loss (Overweight) Devices Companies14 items

Allurion Technologies

Apollo Endosurgery

Helioscopie

Obalon Therapeutics

ReShape Lifesciences

Spatz FGIA

EnteroMedics

MetaCure

Aspire Bariatrics

BarioSurg

BAROnova

GI Dynamics

GI Windows

Scientific Intake

Market Ecosystem

The Minimally Invasive Weight Loss (Overweight) Devices ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream distribution and clinical adoption channels. Value is generated through innovation in device design, regulatory compliance, and efficient delivery to healthcare providers, with capture points distributed across manufacturing, distribution, and post-market support.

Raw material/component suppliers — supply polymers, sensors, and biocompatible materials for device manufacturing.

OEMs/Manufacturers — produce minimally invasive weight loss devices, ensuring compliance with medical device standards.

Technology providers — develop proprietary algorithms and software for device functionality and patient monitoring.

System integrators — assemble and validate multi-component devices for clinical deployment.

Distributors/Channel partners — facilitate market access through hospitals, clinics, and specialty surgical centers.

Service providers/After-sales — manage device maintenance, training, and patient follow-up protocols.

Regulators/Standards bodies — oversee product approvals, safety certifications, and post-market surveillance.

Value flows from suppliers to end-users through coordinated manufacturing and distribution, with regulators and technology providers acting as key control points for innovation pace and market entry. Dependency risks arise from component shortages, evolving regulatory frameworks, or proprietary technology lock-in. Switching costs are elevated for manufacturers reliant on specialized components, while interoperability with existing healthcare systems drives strategic partnerships between OEMs and software developers.

Recent Industry Insights

The Minimally Invasive Weight Loss (Overweight) Devices industry trends have been shaped by strategic collaborations and technological innovation over the past 18 months. Key players, such as Medtronic and Apollo Endosurgery, have strengthened their market presence through partnerships focused on integrating AI-driven analytics into weight management devices, enhancing personalized patient outcomes. Notably, Toward Obesity Therapeutics secured FDA Breakthrough Device Designation for its swallowable gastric volume device, accelerating regulatory pathways and signaling growing acceptance of non-surgical solutions.

Mergers and acquisitions have also intensified, with B. Braun acquiring GiView to expand its endoscopic portfolio, underscoring the industry’s shift toward less invasive procedures. Meanwhile, startups like Innovate Weight Solutions raised $68M in Series C funding to scale production of their adjustable gastric balloon system, reflecting investor confidence in scalable, outpatient-friendly technologies. Regulatory updates, including the EU’s revised MDR guidelines, have prompted manufacturers to prioritize long-term safety data, influencing product development cycles.

Consumer demand is increasingly favoring devices with shorter recovery times and digital connectivity, such as ReShape’s app-integrated adjustable balloon. This trend aligns with rising obesity rates and the adoption of hybrid care models, where remote monitoring complements in-person treatments. Looking ahead, the industry is poised for growth as payers expand coverage for minimally invasive options, driving accessibility and fostering a competitive landscape defined by innovation and strategic alliances.

Analyst Overview

The Minimally Invasive Weight Loss (Overweight) Devices market outlook remains highly attractive, driven by rising obesity prevalence and demand for alternatives to bariatric surgery. Market attractiveness is further bolstered by favorable reimbursement trends and growing patient preference for shorter recovery times. Competitive intensity is moderate, with established players dominating but niche innovators emerging in specialized segments like endoscopic solutions. The long-term outlook is optimistic, with projected CAGR outpacing traditional weight loss methods, though sustained growth hinges on overcoming adoption barriers in emerging markets. Innovation is accelerating, particularly in smart device integration and adjustable implants, enhancing personalization and efficacy. However, demand–supply balance remains skewed, with current capacity struggling to meet rising clinical demand, especially in Asia-Pacific. Key risk factors include regulatory scrutiny, device-related complication litigation, and competition from pharmaceutical advancements. Strategic partnerships and R&D focus on cost reduction will be critical for stakeholders to navigate this dynamic landscape.

12 items

1. Executive Summary

2. Minimally Invasive Weight Loss (Overweight) Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Minimally Invasive Weight Loss (Overweight) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Minimally Invasive Weight Loss (Overweight) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Minimally Invasive Weight Loss (Overweight) Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Minimally Invasive Weight Loss (Overweight) Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Minimally Invasive Weight Loss (Overweight) Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Minimally Invasive Weight Loss (Overweight) Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Minimally Invasive Weight Loss (Overweight) Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Minimally Invasive Weight Loss (Overweight) Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Minimally Invasive Weight Loss (Overweight) Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Minimally Invasive Weight Loss (Overweight) Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Minimally Invasive Weight Loss (Overweight) Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Minimally Invasive Weight Loss (Overweight) Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Minimally Invasive Weight Loss (Overweight) Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Minimally Invasive Weight Loss (Overweight) Devices Market Competition by Key Manufacturers

9.1. Global Minimally Invasive Weight Loss (Overweight) Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Minimally Invasive Weight Loss (Overweight) Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Allurion Technologies

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Apollo Endosurgery

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Helioscopie

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Obalon Therapeutics

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ReShape Lifesciences

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Spatz FGIA

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. EnteroMedics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. MetaCure

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Aspire Bariatrics

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. BarioSurg

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. BAROnova

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. GI Dynamics

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. GI Windows

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Scientific Intake

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Minimally Invasive Weight Loss (Overweight) Devices Market

Figure 4: Global Minimally Invasive Weight Loss (Overweight) Devices Market: Drivers

Figure 5: Global Minimally Invasive Weight Loss (Overweight) Devices Market: Challenges

Figure 6: Global Minimally Invasive Weight Loss (Overweight) Devices Market: Trends

Figure 7: Global Minimally Invasive Weight Loss (Overweight) Devices Market: Opportunity

Figure 8: Global Minimally Invasive Weight Loss (Overweight) Devices Market: Restraint

Figure 9: Global Minimally Invasive Weight Loss (Overweight) Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Minimally Invasive Weight Loss (Overweight) Devices Market Value (USD Million) By Region

Figure 19: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Minimally Invasive Weight Loss (Overweight) Devices Market Value (USD Million) By Region

Figure 27: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By: Regions (2032)

Figure 28: Global Minimally Invasive Weight Loss (Overweight) Devices Market Volume (K) By Region

Figure 29: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Minimally Invasive Weight Loss (Overweight) Devices Market Value (USD Million) By Region

Figure 37: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By: Regions (2032)

Figure 38: Global Minimally Invasive Weight Loss (Overweight) Devices Market Volume (K) By Region

Figure 39: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Minimally Invasive Weight Loss (Overweight) Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Minimally Invasive Weight Loss (Overweight) Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Minimally Invasive Weight Loss (Overweight) Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Minimally Invasive Weight Loss (Overweight) Devices Market Value (USD Million) By Region

Table 14: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Minimally Invasive Weight Loss (Overweight) Devices Market Volume (K) By Region

Table 31: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Minimally Invasive Weight Loss (Overweight) Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Minimally Invasive Weight Loss (Overweight) Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Minimally Invasive Weight Loss (Overweight) Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Allurion Technologies Basic Information And Sales Area

Table 52: Allurion Technologies. Products Portfolio

Table 53: Apollo Endosurgery Basic Information And Sales Area

Table 54: Apollo Endosurgery. Products Portfolio

Table 55: Helioscopie Basic Information And Sales Area

Table 56: Helioscopie. Products Portfolio

Table 57: Obalon Therapeutics Basic Information And Sales Area

Table 58: Obalon Therapeutics. Products Portfolio

Table 59: ReShape Lifesciences Basic Information And Sales Area

Table 60: ReShape Lifesciences. Products Portfolio

Table 61: Spatz FGIA Basic Information And Sales Area

Table 62: Spatz FGIA. Products Portfolio

Table 63: EnteroMedics Basic Information And Sales Area

Table 64: EnteroMedics. Products Portfolio

Table 65: MetaCure Basic Information And Sales Area

Table 66: MetaCure. Products Portfolio

Table 67: Aspire Bariatrics Basic Information And Sales Area

Table 68: Aspire Bariatrics. Products Portfolio

Table 69: BarioSurg Basic Information And Sales Area

Table 70: BarioSurg. Products Portfolio

Table 71: BAROnova Basic Information And Sales Area

Table 72: BAROnova. Products Portfolio

Table 73: GI Dynamics Basic Information And Sales Area

Table 74: GI Dynamics. Products Portfolio

Table 75: GI Windows Basic Information And Sales Area

Table 76: GI Windows. Products Portfolio

Table 77: Scientific Intake Basic Information And Sales Area

Table 78: Scientific Intake. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Minimally Invasive Weight Loss (Overweight) Devices Market Value (USD Million) By Region

Table 88: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Minimally Invasive Weight Loss (Overweight) Devices Market Volume (K) By Region

Table 105: Global Minimally Invasive Weight Loss (Overweight) Devices Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current Minimally Invasive Weight Loss (Overweight) Devices market size?

The market size was valued at USD 1.2 billion in 2023, driven by rising obesity prevalence and demand for less invasive alternatives to traditional bariatric surgery.

2. What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, with the future outlook showing strong expansion in emerging economies.

3. What are the key drivers of market growth?

Key drivers include increasing obesity rates, advancements in endoscopic technologies, and rising patient preference for shorter recovery times over surgical interventions.

4. What challenges does the market face?

Challenges include high treatment costs, regulatory hurdles, and competition from non-invasive weight loss solutions like pharmacotherapies and digital health platforms.

5. Which regions are leading the market?

North America dominates due to advanced healthcare infrastructure, while Europe and Asia-Pacific show rapid growth, driven by improving access to bariatric care.

6. Who are the top companies in this space?

Leading firms include Medtronic, B. Braun, Apollo Endosurgery, and Allurion Technologies, which focus on innovation to strengthen their Minimally Invasive Weight Loss (Overweight) Devices market position.

7. What future opportunities exist for this market?

Opportunities lie in expanding into underserved regions, integrating AI for personalized treatments, and developing cost-effective devices to enhance affordability.

8. How is technology impacting this market?

Technology impact is significant, with endoscopic suturing systems, gastric balloons, and swallowable capsules driving adoption due to reduced risks and faster outcomes.

9. What is the regulatory landscape like?

Regulatory frameworks vary by region, with the FDA in the U.S. and EMA in Europe requiring rigorous clinical trials, while emerging markets face slower approval processes.

10. How are consumer trends shaping the market?

Growing awareness of obesity-related health risks and social stigma is increasing patient willingness to adopt minimally invasive solutions, boosting device adoption rates.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Minimally Invasive Weight Loss (Overweight) Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allurion Technologies; Apollo Endosurgery; Helioscopie; Obalon Therapeutics; ReShape Lifesciences; Spatz FGIA; EnteroMedics; MetaCure; Aspire Bariatrics; BarioSurg; BAROnova; GI Dynamics; GI Windows; Scientific Intake
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options